Bank of Nova Scotia Makes New $1.77 Million Investment in IDEX Corporation $IEX

Bank of Nova Scotia acquired a new stake in shares of IDEX Corporation (NYSE:IEX) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 7,797 shares of the industrial products company’s stock, valued at approximately $1,770,000.

A number of other institutional investors have also recently made changes to their positions in IEX. BlackRock Inc. purchased a new position in IDEX during the 2nd quarter valued at approximately $1,301,393,000. Primecap Management Co. CA raised its holdings in shares of IDEX by 86.5% during the 4th quarter. Primecap Management Co. CA now owns 3,226,787 shares of the industrial products company’s stock worth $574,174,000 after acquiring an additional 1,496,207 shares in the last quarter. State Street Corp raised its holdings in shares of IDEX by 0.6% during the 4th quarter. State Street Corp now owns 3,172,410 shares of the industrial products company’s stock worth $564,499,000 after acquiring an additional 17,668 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of IDEX by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 2,034,942 shares of the industrial products company’s stock valued at $360,740,000 after acquiring an additional 7,844 shares during the last quarter. Finally, Van ECK Associates Corp grew its holdings in shares of IDEX by 3.3% in the fourth quarter. Van ECK Associates Corp now owns 1,976,856 shares of the industrial products company’s stock valued at $351,762,000 after purchasing an additional 63,699 shares in the last quarter. Hedge funds and other institutional investors own 97.96% of the company’s stock.

IDEX Stock Up 2.0%

Shares of IEX opened at $234.91 on Thursday. The company has a quick ratio of 2.15, a current ratio of 3.05 and a debt-to-equity ratio of 0.46. The business has a fifty day moving average of $228.47 and a 200 day moving average of $213.48. The company has a market cap of $17.32 billion, a PE ratio of 33.80, a P/E/G ratio of 2.17 and a beta of 0.98. IDEX Corporation has a 52-week low of $158.19 and a 52-week high of $243.80.

IDEX (NYSE:IEX) last posted its quarterly earnings data on Wednesday, July 29th. The industrial products company reported $2.32 earnings per share for the quarter, beating analysts’ consensus estimates of $2.11 by $0.21. IDEX had a net margin of 14.49% and a return on equity of 15.69%. The business had revenue of $920.60 million for the quarter, compared to analysts’ expectations of $905.38 million. During the same quarter in the previous year, the business posted $2.07 earnings per share. The business’s revenue was up 6.4% compared to the same quarter last year. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. On average, sell-side analysts expect that IDEX Corporation will post 8.82 EPS for the current year.

IDEX Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Monday, July 6th were issued a dividend of $0.73 per share. This represents a $2.92 annualized dividend and a yield of 1.2%. The ex-dividend date was Monday, July 6th. IDEX’s dividend payout ratio is presently 42.01%.

Key Headlines Impacting IDEX

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Zacks increased its FY2026 EPS estimate to $8.71 from $8.70, Q4 2026 to $2.20 from $2.18, and Q1 2027 to $2.12 from $2.11.
• Positive Sentiment: Longer-term estimates also improved: FY2027 EPS rose to $9.26 from $9.21, Q4 2027 to $2.42 from $2.38, Q1 2028 to $2.38 from $2.36, and FY2028 to $10.54 from $10.45. The revisions imply continued earnings growth, although the increases were relatively small.
• Positive Sentiment: The revised FY2026 estimate of $8.71 remains close to the broader analyst consensus of $8.82. IDEX’s latest reported quarter also showed earnings and revenue ahead of expectations, with EPS of $2.32 and revenue of $920.6 million, up 6.4% year over year.
• Neutral Sentiment: The six Zacks updates largely repeat the same forecast changes rather than representing separate fundamental developments. Investors may view them as supportive, but the limited size of the revisions may constrain their impact.
• Neutral Sentiment: IDEX shares have increased and are trading near the upper end of their 52-week range, above both their 50-day and 200-day moving averages. With a market capitalization of approximately $17.3 billion and a forward-looking valuation near 27 times earnings, further gains may depend on the company converting the raised forecasts into actual results.
• Neutral Sentiment: A separate report concerns IDEX Biometrics ASA (OTC: IDXAF), which granted incentive subscription rights to two senior employees. That company is unrelated to IDEX Corporation and should not affect IEX shares. IDEX Biometrics executive incentive rights announcement

Insiders Place Their Bets

In related news, CAO Lisa M. Anderson sold 385 shares of the stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total value of $91,857.15. Following the sale, the chief accounting officer directly owned 4,327 shares of the company’s stock, valued at $1,032,378.93. This represents a 8.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.50% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on IEX. Oppenheimer restated an “outperform” rating and issued a $265.00 price target on shares of IDEX in a research report on Thursday, July 30th. Stifel Nicolaus lifted their price objective on shares of IDEX from $257.00 to $268.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Mizuho upgraded shares of IDEX from a “neutral” rating to an “outperform” rating and boosted their target price for the stock from $210.00 to $280.00 in a report on Tuesday, August 11th. Citigroup upped their target price on shares of IDEX from $252.00 to $269.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. Finally, Seaport Research Partners reaffirmed a “buy” rating and issued a $250.00 price target on shares of IDEX in a report on Tuesday, May 5th. Eight analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, IDEX presently has a consensus rating of “Moderate Buy” and a consensus target price of $260.80.

IDEX Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.